Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
Senexis Limited logo — Small-molecule therapies targeting amyloid protein toxicity

Senexis Limited

Small-molecule therapies targeting amyloid protein toxicity

Founded 2001 United Kingdom Cambridge, United Kingdom 3 employees Unknown Total: $4.30M Biotechnology, Life Sciences +1

General Information

Company Name Senexis Limited
Founded Year 2001
Location United Kingdom Cambridge, United Kingdom +1
Employees 3
Industries Biotechnology, Life Sciences, Pharmaceutical
Funding Stage Unknown
Social

Get notified when Senexis Limited moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Senexis Limited

Senexis Limited is a promising biotechnology startup, leveraging its expertise in small-molecule therapies to address amyloid protein toxicity-related diseases. Founded in 2001, the company is headquartered in the United Kingdom and operates within the Biotechnology, Life Sciences, and Pharmaceutical industries.

Senexis is committed to pioneering breakthroughs in treating ailments associated with ageing. Their current focus is on developing innovative therapies aimed at combating Alzheimer's disease, a significant area of need within the healthcare sector. This focus positions them well in the market as demand for effective treatments rises.

The startup's last known funding was an Early VC investment of £2.90M from the Wellcome Trust on 01 January 2008. This investment reflects a strong vote of confidence from a reputable institution, underscoring the potential for Senexis's pipeline to yield impactful results.

Taxonomy: small-molecule drug discovery, amyloid protein toxicity, ageing-related diseases, Alzheimer's disease treatment, protein misfolding, amyloid-related toxicity, therapeutic agents, neurodegenerative diseases, R&D in CNS, protein aggregation inhibitors, inflammation inhibition, drug development, novel treatments, pathogenic process inhibition

Services & Products

selling premium domain names
leasing domains with purchase option
secure transaction facilitation
customer support for domain acquisition

Target Customers

entrepreneurs startups business owners investors digital marketers

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Early VC £2.90M 1
Wellcome Trust
01 Jan 2008
Seed £1.40M 2
Wellcome Trust
BTG 		01 Feb 2003

Senexis Limited Alternatives & Competitors

Senexis Limited vs
Klogene Therapeutics, Inc.
Klogene Therapeutics, Inc.

Creating therapeutics to prevent and treat age-related diseases by boosting natural Klotho protein l...

Pre Seed
Biotechnology, Health Care
Senexis Limited vs
Korsana Biosciences
Korsana Biosciences United States

Therapeutics for neurodegenerative diseases targeting amyloid beta

IPO
26 employees
Biotechnology
Senexis Limited vs
Cardurion Pharmaceuticals
Cardurion Pharmaceuticals United States

Translating the science of cardiac myocyte signaling pathways into groundbreaking therapeutics

Series B
80 employees
Biotechnology, Health Care

FAQ About Senexis Limited

Small-molecule therapies targeting amyloid protein toxicity
Senexis Limited was founded in 2001.
Senexis Limited is headquartered in Cambridge, United Kingdom.
Senexis Limited operates in the following industries: Biotechnology, Life Sciences, Pharmaceutical.
Senexis Limited has approximately 3 employees.
Senexis Limited has completed 2 funding rounds, raising a total of $4.30M. The latest funding stage is Unknown.
Senexis Limited offers: selling premium domain names, leasing domains with purchase option, secure transaction facilitation, customer support for domain acquisition.
Top alternatives and competitors to Senexis Limited include Klogene Therapeutics, Inc., Korsana Biosciences, Cardurion Pharmaceuticals, AnHorn Medicines, Aclaris Therapeutics, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Senexis Limited and Klogene Therapeutics, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Senexis Limited and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy